Group One Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-92,379
Closed -$281K 3815
2024
Q4
$281K Buy
+92,379
New +$281K ﹤0.01% 790
2024
Q3
Hold
0
3258
2024
Q2
Hold
0
3293
2024
Q1
Sell
-157,445
Closed -$1.38M 3405
2023
Q4
$1.38M Buy
157,445
+73,327
+87% +$645K ﹤0.01% 318
2023
Q3
$965K Buy
84,118
+75,341
+858% +$864K ﹤0.01% 382
2023
Q2
$222K Sell
8,777
-19,016
-68% -$481K ﹤0.01% 669
2023
Q1
$895K Sell
27,793
-92,297
-77% -$2.97M ﹤0.01% 331
2022
Q4
$2.22M Buy
+120,090
New +$2.22M 0.01% 225
2022
Q3
Sell
-4,637
Closed -$64K 3400
2022
Q2
$64K Sell
4,637
-15,693
-77% -$217K ﹤0.01% 1215
2022
Q1
$396K Buy
+20,330
New +$396K ﹤0.01% 816
2021
Q4
Sell
-316
Closed -$9K 3442
2021
Q3
$9K Sell
316
-7,722
-96% -$220K ﹤0.01% 1853
2021
Q2
$238K Buy
8,038
+1,551
+24% +$45.9K ﹤0.01% 1050
2021
Q1
$181K Sell
6,487
-5,500
-46% -$153K ﹤0.01% 1057
2020
Q4
$340K Sell
11,987
-534
-4% -$15.1K ﹤0.01% 727
2020
Q3
$315K Buy
12,521
+11,832
+1,717% +$298K ﹤0.01% 664
2020
Q2
$17K Buy
689
+623
+944% +$15.4K ﹤0.01% 1088
2020
Q1
$1K Sell
66
-7,409
-99% -$112K ﹤0.01% 1310
2019
Q4
$121K Buy
+7,475
New +$121K ﹤0.01% 760
2019
Q3
Sell
-199
Closed -$3K 2258
2019
Q2
$3K Hold
199
﹤0.01% 1129
2019
Q1
$3K Buy
+199
New +$3K ﹤0.01% 1103
2018
Q4
Hold
0
2164
2018
Q3
Hold
0
2166
2018
Q2
Sell
-12
Closed 2103
2018
Q1
$0 Sell
12
-186
-94% ﹤0.01% 2024
2017
Q4
$7K Sell
198
-802
-80% -$28.4K ﹤0.01% 1209
2017
Q3
$28K Buy
+1,000
New +$28K ﹤0.01% 993
2017
Q2
Hold
0
1939
2017
Q1
Sell
-801
Closed -$17K 1910
2016
Q4
$17K Sell
801
-1,000
-56% -$21.2K ﹤0.01% 1022
2016
Q3
$29K Buy
1,801
+380
+27% +$6.12K ﹤0.01% 857
2016
Q2
$19K Sell
1,421
-2,800
-66% -$37.4K ﹤0.01% 896
2016
Q1
$74K Sell
4,221
-3,100
-42% -$54.3K ﹤0.01% 654
2015
Q4
$250K Buy
7,321
+6,621
+946% +$226K ﹤0.01% 519
2015
Q3
$21K Buy
+700
New +$21K ﹤0.01% 1100
2015
Q2
Sell
-2,300
Closed -$48K 1851
2015
Q1
$48K Buy
+2,300
New +$48K ﹤0.01% 835
2014
Q4
Hold
0
1924